Strategic acquisitions Intersurgical is accelerating growth through major asset acquisitions in acute care and interventional urology for around $530 million, signaling readiness to expand high-value product lines and clinical offerings that could open new hospital and specialty accounts.

Expansion footprint Recent office expansions in Lithuania and Northern Europe indicate an expanding regional presence. This creates opportunities to engage local procurement teams and align supply chains for broader hospital networks and distribution partners.

Integrated solutions With a broad portfolio spanning airway management, anesthesia, critical care, and oxygen therapy, there are cross-sell opportunities to upsell bundled respiratory care packages to existing customers including hospitals, prehospital services, and home care providers.

New product launches Launch of AccuPAP therapy system and i-gel related packs demonstrates ongoing innovation. Sales teams can target facilities expanding PPV and airway management capabilities, highlighting value in preventing atelectasis and improving patient flow.

Public momentum Publicity around significant deals and product introductions signals a market push and potential appetite from customers for scalable, safety-focused respiratory solutions, offering opportunities to engage senior clinicians and procurement on long-term modernization projects.